Evidence map›Paper›PMID 39944233›Full record

ArticleHemaSphere2025

Single-cell DNA and surface protein characterization of high hyperdiploid acute lymphoblastic leukemia at diagnosis and during treatment.

Margo Aertgeerts, Sarah Meyers, Olga Gielen, Jochen Lamote, Barbara Dewaele, Mercedeh Tajdar, Johan Maertens, Jolien De Bie, Kim De Keersmaecker, Nancy Boeckx and 5 more

Abstract read
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Margo AertgeertsDepartment of Oncology KU Leuven Leuven Belgium.
Sarah MeyersCenter for Cancer Biology VIB Leuven Belgium.ORCID 0000-0002-9592-8850
Olga GielenCenter for Cancer Biology VIB Leuven Belgium.
Jochen LamoteCenter for Cancer Biology VIB Leuven Belgium.
Barbara DewaeleDepartment of Human Genetics KU Leuven Leuven Belgium.
Mercedeh TajdarDepartment of Microbiology, Immunology and Transplantation KU Leuven Leuven Belgium.
Johan MaertensLeuvens Kanker Instituut (LKI) KU Leuven - UZ Leuven Leuven Belgium.
Jolien De BieCenter of Human Genetics UZ Leuven Leuven Belgium.
Kim De KeersmaeckerDepartment of Oncology KU Leuven Leuven Belgium.
Nancy BoeckxDepartment of Oncology KU Leuven Leuven Belgium.
Lucienne MichauxDepartment of Human Genetics KU Leuven Leuven Belgium.
Anne UyttebroeckDepartment of Oncology KU Leuven Leuven Belgium.
Sofie DemeyerCenter for Cancer Biology VIB Leuven Belgium.
Heidi SegersDepartment of Oncology KU Leuven Leuven Belgium.
Jan CoolsCenter for Cancer Biology VIB Leuven Belgium.ORCID https://orcid.org/0000-0001-6626-5843

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High hyperdiploid (HeH) B-cell acute lymphoblastic leukemia (B-ALL) is the most prevalent subtype of childhood ALL. This leukemia is characterized by trisomies and tetrasomies of specific chromosomes and additional point mutations. Here, we used single-cell targeted DNA and antibody sequencing to determine the clonal evolution of HeH B-ALL during development and chemotherapy treatment. Chromosomal copy number changes were mostly stable over all the leukemia cells, while mutations were typically subclonal. Within all 13 cases, at least one

Identifiers

PMID39944233
PMCPMC11814536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.